Objective To characterise the changing trends in the pharmacological management of SLE in the USA between 2007 and 2023 as ...

Sana Biotechnology results from the phase 1 study using SC291 for the treatment of patients with SLE are expected in 2025.

Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune ...

Fate Therapeutics has announced encouraging initial data from the FT819 phase 1 autoimmunity study for people with ...

In a new study, researchers surveyed people living with systemic lupus erythematosus (SLE) to examine if demographic factors such as age, race/ethnicity, and geographic location, influence health and ...

Study reveals that achieving low disease activity or remission in lupus patients with high disease activity reduces organ ...

Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.

ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.

Yes, lupus can affect your voice. Lupus can cause inflammation and tissue damage, leading to hoarseness, vocal fatigue, and ...

Lupus and menopause can interact in complex ways, with menopause sometimes worsening lupus symptoms or, in other cases, ...

Women with systemic lupus erythematosus face an increased risk for cervical cancer ... women with SLE has been linked to the ...

Despite following the same basic recommendations as the adult guidelines, the pediatric LN guidelines included special ...